With just over three months before the U.S. elections in November, President Donald Trump is making a last-ditch effort to stamp his name on a drug pricing deal that has eluded him over his first three years in office.
A slate of four executive orders, announced by Trump on Friday, revive previously attempted drug pricing restraints that have languished politically. While the orders signal a renewed push, the barriers to achieving their aims are no lower than they have been in the past.
